<SEC-DOCUMENT>0001209191-21-045789-index.html : 20210707 <SEC-HEADER>0001209191-21-045789.hdr.sgml : 20210707 <ACCEPTANCE-DATETIME>20210707162300 ACCESSION NUMBER: 0001209191-21-045789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210702 FILED AS OF DATE: 20210707 DATE AS OF CHANGE: 20210707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoppenot Herve CENTRAL INDEX KEY: 0001596492 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 211077658 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION-EXPERIMENTAL STN. STREET 2: ROUTE 141 & HENRY CLAY RD., BLDG. E336 CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>doc4.xml <DESCRIPTION>FORM 4 SUBMISSION <TEXT> Document 1 - file: doc4.html
Document 1 - RAW XML: doc4.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24.1 <SEQUENCE>2 <FILENAME>attachment1.htm <DESCRIPTION>EX-24.1 DOCUMENT <TEXT> Document 2 - file: attachment1.htm
</DOCUMENT> </SEC-DOCUMENT>